Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Vivanza Biosciences Ltd

Your Vote -

Buy

50.00%

Hold

25.00%

Sell

25.00%

50.00%

4 users have voted

No Records Found

Option Chain

Analyzes market sentiment, predicts Vivanza Biosciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Vivanza Biosciences - Board Meeting Intimation for Consideration And Approved The Un-Audited Standalone And Consolidated Fina

    8 Aug 2025, 2:29PM Vivanza Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2025 ,inter alia, to consider
  • Vivanza Biosciences has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 7:05AM As of June 2025, 20.02% is owned by Indian Promoters and 79.98% by Public. <p align=justify> Top two Promoters holding highest number of shares of Viv
  • Vivanza Biosciences - Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligatio

    14 Jul 2025, 3:02PM Non-Applicability of Statement of Deviation or Variation under Regulation 32 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 201
  • Vivanza Biosciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Jul 2025, 2:29PM Certificate under Reg.74(5) of SEBI(DP), Regulations, 2018 for June Quarter ended
  • Vivanza Biosciences - Newspaper Publication

    14 May 2025, 3:56PM Newspaper Publication - The extract of Audited Standalone and Consolidated Financial Results for the Quarter and Financial year ended on March 31, 202
  • Vivanza Biosciences - Clarification On Typographical Error

    13 May 2025, 2:50PM Revised Outcome of the Board Meeting pertaining to clarification on Typographical Error in the Notes related to Financial Results submission for the q

Key fundamentals

Evaluate the intrinsic value of Vivanza Biosciences Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 10.113 7.9781 10.9623 5.5128 3.5404
Liabilities 10.113 7.9781 10.9623 5.5128 3.5404
Equity 4 4 4 4 4
Gross Profit -0.3635 0.7998 0.7212 0.049 0.1259
Net Profit -0.6951 0.3174 0.5691 0.4636 0.0998
Cash From Operating Activities -2.4688 1.7835 0.1607 -0.6771 -3.0778
NPM(%) -23.62 2.2 4 5.06 1.08
Revenue 2.9428 14.4132 14.2071 9.1475 9.2233
Expenses 3.3063 13.6134 13.4859 9.0984 9.0973
ROE(%) -14.12 6.45 11.56 9.42 2.02

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Vivanza Biosciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 799.95 -0.83 72.61 1.19 301.39 0.62
Lotus Eye Hospital and Institute Ltd 73.85 1.16 210.74 4.35 3.55 0.00
Bharat Immunological and Biologicals Corporation Ltd 21.35 -0.42 0.00 9.02 -39.50 0.00
Astec Lifesciences Ltd 822.00 3.70 0.00 4.10 -601.21 0.00

Company Info

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Ivee Injectaa Limited is engaged in the manufacture of Large Volume Parenterals (LVPs) and diversifying into manufacture of Small Volume Parenterals (SVPs) and other allied activities. The company is listed on Bombay Stock Exchange. 2012 -Change of Share Registrar and Transfer Agent from M/s. Link Intime India Private Limited to M/s. Purva Sharegistry India Private Limited. 2015 -The name of the company has been changed from Ivee Injectaa Ltd. to Vivanza Biosciences Ltd. 2023 -The Company has splits its face value from Rs. 10/- to Rs. 1/-.

Read More

Parent Organisation

Vivanza Biosciences Ltd.

Founded

06/03/1982

Managing Director

Mr.J A Mehta

NSE Symbol

FAQ

The current price of Vivanza Biosciences Ltd is

The 52-week high for Vivanza Biosciences Ltd is

The market capitalization of Vivanza Biosciences Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Vivanza Biosciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Vivanza Biosciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Vivanza Biosciences Ltd shares.

The CEO of Vivanza Biosciences Ltd is Mr.J A Mehta, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT